Search Results - "Baker, Joshua F."

Behavioral Incentives for Exercise and Intra‐Articular Glucocorticoids for Knee Osteoarthritis: Results From a Factorially Designed Pragmatic Randomized Clinical Trial.

Authors: Baker, Joshua F. Wysham, Katherine D. Quinones, Mercedes et al.

Source: Arthritis & Rheumatology. Apr2026, p1. 11p. 5 Illustrations.

Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting.

Authors: Baker, Joshua F. Bakewell, Catherine Dikranian, Ara et al.

Source: Rheumatology & Therapy. Jun2024, Vol. 11 Issue 3, p841-853. 13p.

Risk Factors for Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Among Patients With Relapse After Induction of Remission With Rituximab.

Authors: Romich, Ellen Baker, Joshua F. Riley IV, Thomas R. et al.

Source: Arthritis & Rheumatology. Dec2025, p1. 11p. 2 Illustrations.

Real-World Use and Effectiveness Outcomes in Patients with Rheumatoid Arthritis Treated with Upadacitinib: An Analysis from the CorEvitas Registry.

Authors: Baker, Joshua F. Zueger, Patrick Ali, Mira et al.

Source: Rheumatology & Therapy. Apr2024, Vol. 11 Issue 2, p363-380. 18p.

Peripheral Biomarker Signatures in Rheumatoid Arthritis–Associated Interstitial Lung Disease.

Authors: Wheeler, Austin M. Baker, Joshua F. Riley, Thomas R. et al.

Source: Arthritis & Rheumatology. Aug2025, Vol. 77 Issue 8, p971-980. 10p.

Changes in physical function over time in rheumatoid arthritis patients: A cohort study.

Authors: Santo, Rafaela Cavalheiro do Espírito Baker, Joshua F. dos Santos, Leonardo Peterson et al.

Source: PLoS ONE. 1/23/2023, Vol. 18 Issue 1, p1-16. 16p.

Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis.

Authors: Baker, Joshua F. Reed, George Mikuls, Ted R. et al.

Source: Arthritis & Rheumatology. Mar2025, Vol. 77 Issue 3, p263-271. 9p.

Development and internal validation of a clinical and genetic risk score for rheumatoid arthritis-associated interstitial lung disease.

Authors: Wheeler, Austin M Baker, Joshua F Riley, Thomas et al.

Source: Rheumatology. Jan2025, Vol. 64 Issue 1, p268-275. 8p.

Association of Cardiovascular Outcomes With Low‐Dose Glucocorticoid Prescription in Patients With Rheumatoid Arthritis.

Authors: Coburn, Brian W. Baker, Joshua F. Hsu, Jesse Y. et al.

Source: Arthritis & Rheumatology. Nov2024, Vol. 76 Issue 11, p1585-1593. 9p.

Reply.

Authors: Baker, Joshua F. Scanzello, Carla R.

Source: Arthritis & Rheumatology. Jun2026, p1. 1p.

Associations Between Low Serum Urate, Body Composition, and Mortality.

Authors: Baker, Joshua F. Weber, David R. Neogi, Tuhina et al.

Source: Arthritis & Rheumatology. Jan2023, Vol. 75 Issue 1, p133-140. 8p.

impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease.

Authors: Brooks, Rebecca Baker, Joshua F Yang, Yangyuna et al.

Source: Rheumatology. Dec2022, Vol. 61 Issue 12, p4667-4677. 11p.

Elevations in adipocytokines and mortality in rheumatoid arthritis.

Authors: Baker, Joshua F England, Bryant R George, Michael D et al.

Source: Rheumatology. Dec2022, Vol. 61 Issue 12, p4924-4934. 11p.

Invited Commentary: A Step Toward Safer and More Precise Management of Osteoarthritis Pain.

Authors: Baker, Joshua F Joshua.Baker@pennmedicine.upenn.edu

Source: American Journal of Epidemiology. Sep2023, Vol. 192 Issue 9, p1449-1451. 3p.

Sarcopenic obesity in rheumatoid arthritis: prevalence and impact on physical functioning.

Authors: Baker, Joshua F Giles, Jon T Weber, David et al.

Source: Rheumatology. Jun2022, Vol. 61 Issue 6, p2285-2294. 10p.

Performance of an Idiopathic Pulmonary Fibrosis–Derived Multibiomarker Panel for Rheumatoid Arthritis–Associated Interstitial Lung Disease.

Authors: Luedders, Brent A. Kass, Daniel Baker, Joshua F. et al.

Source: Arthritis & Rheumatology. Feb2026, Vol. 78 Issue 2, p302-310. 9p.

Evaluation of the impact of age and adiposity on a multi-biomarker disease activity score before and after adjustment.

Authors: Baker, Joshua F. Curtis, Jeffrey R. Chernoff, David et al.

Source: Clinical Rheumatology. Jun2021, Vol. 40 Issue 6, p2419-2426. 8p.

Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study.

Authors: George, Michael D. Baker, Joshua F. Winthrop, Kevin et al.

Source: Annals of Internal Medicine. 12/1/2020, Vol. 173 Issue 11, p870-878. 9p. 4 Charts, 1 Graph.

MUC5B promoter variant and survival in rheumatoid arthritis-associated interstitial lung disease.

Authors: Klein, Jacob Wheeler, Austin M Baker, Joshua F et al.

Source: Rheumatology. 2025 Supplement, Vol. 64, pSI47-SI54. 8p.

Risk of Nonunion with Nonselective NSAIDs, COX-2 Inhibitors, and Opioids.

Authors: George, Michael D. Baker, Joshua F. Leonard, Charles E. et al.

Source: Journal of Bone & Joint Surgery, American Volume. 7/15/2020, Vol. 102 Issue 14, p1230-1238. 9p.